Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia
Author(s) -
Ikwo Oboho,
Anna M. Bramley,
Lyn Finelli,
Alicia M. Fry,
Krow Ampofo,
Sandra R. Arnold,
Wesley H. Self,
Derek J. Williams,
D. Mark Courtney,
Yuwei Zhu,
Evan J. Anderson,
Carlos G. Grijalva,
Jonathan A. McCullers,
Richard G. Wunderink,
Andrew T. Pavia,
Kathryn M. Edwards,
Seema Jain
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw254
Subject(s) - medicine , oseltamivir , pneumonia , community acquired pneumonia , pediatrics , intensive care medicine , covid-19 , disease , infectious disease (medical specialty)
Among patients hospitalized with CAP during influenza season, oseltamivir treatment was moderate overall and associated with clinician-ordered testing, severe illness, and specific hospitals. Increased clinician education is needed to include influenza in the differential diagnosis for hospitalized CAP patients and to test and treat patients empirically if influenza is suspected.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom